239 related articles for article (PubMed ID: 34733971)
21. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
22. CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.
Zhu N; Yang Y; Wang H; Tang P; Zhang H; Sun H; Gong L; Yu Z
Front Oncol; 2022; 12():822849. PubMed ID: 35574409
[TBL] [Abstract][Full Text] [Related]
23. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.
Chen Y; Meng Z; Zhang L; Liu F
Front Immunol; 2021; 12():664845. PubMed ID: 33968066
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.
Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K
J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245
[TBL] [Abstract][Full Text] [Related]
26. [CD40LG is a novel immune- and stroma-related prognostic biomarker in the tumor microenvironment of invasive breast cancer].
Guo L; Ma Y; Li T; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1267-1278. PubMed ID: 36210698
[TBL] [Abstract][Full Text] [Related]
27. Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Li J; Sun C
Pharmgenomics Pers Med; 2021; 14():15-26. PubMed ID: 33447073
[TBL] [Abstract][Full Text] [Related]
28. TGFβ1: An Indicator for Tumor Immune Microenvironment of Colon Cancer From a Comprehensive Analysis of TCGA.
Wang J; Wang J; Gu Q; Yang Y; Ma Y; Zhang Q
Front Genet; 2021; 12():612011. PubMed ID: 33995472
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Hub Genes in the Immune Microenvironment of Lung Adenocarcinoma by Estimation.
Liu S; Tian W; Li B
Comb Chem High Throughput Screen; 2022; 25(1):77-89. PubMed ID: 33308118
[TBL] [Abstract][Full Text] [Related]
30. A Naive Bayes model on lung adenocarcinoma projection based on tumor microenvironment and weighted gene co-expression network analysis.
Ye Z; Song P; Zheng D; Zhang X; Wu J
Infect Dis Model; 2022 Sep; 7(3):498-509. PubMed ID: 36091346
[TBL] [Abstract][Full Text] [Related]
31. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
32. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive characterization of alternative splicing events related to prognosis and the tumor microenvironment in lung adenocarcinoma.
Ma S; Zhu J; Wang M; Han T; Zhu J; Jiang R; Jiang T
Ann Transl Med; 2022 Apr; 10(8):479. PubMed ID: 35571443
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
35. Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma.
Ma C; Luo H; Cao J; Zheng X; Zhang J; Zhang Y; Fu Z
Front Mol Biosci; 2020; 7():571641. PubMed ID: 33102522
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.
Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ
Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345
[No Abstract] [Full Text] [Related]
37. The Correlation Between SPP1 and Immune Escape of EGFR Mutant Lung Adenocarcinoma Was Explored by Bioinformatics Analysis.
Zheng Y; Hao S; Xiang C; Han Y; Shang Y; Zhen Q; Zhao Y; Zhang M; Zhang Y
Front Oncol; 2021; 11():592854. PubMed ID: 34178613
[TBL] [Abstract][Full Text] [Related]
38. Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma.
Liu J; Shen H; Gu W; Zheng H; Wang Y; Ma G; Du J
Front Immunol; 2022; 13():960738. PubMed ID: 36032135
[TBL] [Abstract][Full Text] [Related]
39. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
40. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]